Application of herba hydrocotylis liver-curing tablets in preparation of medicine for inhibiting cell proliferation of lymphoma cell U-937

The technology of U-937 and lymphoma cells is applied in the field of preparation of Tianhu Coriander Yugan Tablets, which can solve the problems of large dosage, many impurities, and inconvenient taking of patients, and achieve the effect of reducing dosage.

Inactive Publication Date: 2016-05-25
JINAN XINSHIDAI MEDICINE SCI & TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In the prior art, there is no report on the application of Tian Huan Yu Gan Tablets in the preparation of drugs for inhibiting the proliferation of human lymphoma cell U-937 cells, and there is no report on the use of supercritical extraction in the extraction and preparation of Tian Hu Xian Yu Gan Tablets. The traditional method of decocting in water, the process is rough and backward, and there are many impurities, which leads to excessive dosage for patients and is inconvenient to take, which seriously affects the clinical application of this product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Take 699g of coriander, 1398g of apricot leaves, 699g of sorrel, and 209g of scorpion grass, and add them to CO 2 In the supercritical extractor, ethanol is used as an entrainer, and the volume percentage of the entrainer to the total extraction solvent is 5%, the extraction pressure is 25MPa, the temperature is 40°C, and the CO 2 The flow rate is 2ml / g crude drug·min, the extraction time is 900min, and the supercritical extract is obtained. The supercritical extract is added to starch and 70% ethanol to make granules, dried, and pressed into tablets to make 500 tablets, each weighing 0.30g.

[0025] After testing, the content of oleanolic acid in the finished product is 6.45mg / tablet.

Embodiment 2

[0027] Take 699g of coriander, 1398g of apricot leaves, 699g of sorrel, and 209g of scorpion grass, and add them to CO 2 In a supercritical extractor, ethanol is used as an entrainer, and the entrainer accounts for 4% by volume of the total extraction solvent. The extraction pressure is 15MPa, the temperature is 30°C, and the CO 2 The flow rate is 1ml / g crude drug·min, the extraction time is 1000min, and the supercritical extract is obtained. The supercritical extract is added to starch and 70% ethanol to make granules, dried, and pressed into tablets to make 500 tablets, each weighing 0.30g.

[0028] After testing, the content of oleanolic acid in the finished product is 4.98mg / tablet.

Embodiment 3

[0030] Take 699g of coriander, 1398g of apricot leaves, 699g of sorrel, and 209g of scorpion grass, and add them to CO 2 In the supercritical extractor, ethanol is used as an entrainer, and the volume percentage of the entrainer in the total extraction solvent is 6%, the extraction pressure is 30MPa, the temperature is 60°C, and the CO 2 The flow rate is 3ml / g crude drug·min, the extraction time is 800min, and the supercritical extract is obtained. The supercritical extract is added to starch and 70% ethanol to make granules, dried, and pressed into tablets to make 500 tablets, each weighing 0.30g.

[0031] After testing, the content of oleanolic acid in the finished product is 3.22mg / tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to an application of herba hydrocotylis liver-curing tablets in preparation of a medicine for inhibiting the cell proliferation of lymphoma cell U-937 and a preparation method of herba hydrocotylis liver-curing tablets. The herba hydrocotylis liver-curing tablets are prepared from the active pharmaceutical ingredients including 699g of herba hydrocotylis, 1,398g of herba pimpinellae, 699g of oxalis corniculata and 209g of brooklet anemone root by supercritical extraction, wherein the content of oleanolic acid is greatly increased.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to the application of Tianhuxian Yugan Tablets in the preparation of drugs for inhibiting the proliferation of lymphoma cell U-937 cells and the preparation method of Tianhuxian Yugan Tablets. Background technique [0002] The standard number of Tianhuxian Yugan Tablets is WS-10213 (ZD-0213)-2002, which is recorded in the Hepatobiliary Subvolume of the National Compilation of Chinese Patent Medicine Standards. It is made from 699g of coriander, 1398g of apricot leaves, 699g of sorrel, and 209g of tiger palm as raw materials. It has the effects of clearing away heat and detoxifying, soothing the liver and promoting gallbladder. [0003] In the prior art, there is no report on the application of Tian Huan Yu Gan Tablets in the preparation of drugs for inhibiting the proliferation of human lymphoma cell U-937 cells, and there is no report on the use of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/71A61K9/20A61P35/00
CPCA61K36/23A61K9/2059A61K36/185A61K36/71A61K2236/37A61K2300/00
Inventor 王梅
Owner JINAN XINSHIDAI MEDICINE SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap